Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2017

03.06.2017

Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis

verfasst von: Angelo Valerio Marzano, Maria Gabriella Raimondo, Emilio Berti, Pier Luigi Meroni, Francesca Ingegnoli

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Skin lesions are frequent manifestations of underlying systemic conditions, including systemic autoimmune vasculitis. In particular, anti-neutrophil cytoplasmic antibodies (ANCA) are associated with distinct forms of vasculitis characterized by inflammatory cell infiltration of the walls of small and medium-sized vessels leading to vascular destruction and tissue necrosis. ANCA-associated vasculitis is rare and systemic diseases, which can be classified based on different distribution of vascular inflammation and presence or absence of granulomatosis and asthma. Despite their diversities, ANCA-associated vasculitis, namely microscopic polyangiitis, granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis, can all display a broad variety of cutaneous manifestations, which can appear during the course of the disease or even as first sign at the time of onset. Different skin manifestations might coexist in the same patient and occur in different occasions during the course of the vasculitis. Thus, a deep knowledge of the spectrum of skin lesions as part of ANCA-associated vasculitis is mandatory for a correct diagnostic process, whenever cutaneous vasculitis is suspected. Due to this broad variety of manifestations, the diagnosis of skin involvement in ANCA-associated vasculitis is very challenging and it must be supported by a detailed medical history, accurate physical examination, specific histopathological analysis of skin biopsy and the presence of ANCA serology. In this review, we focus on the cutaneous manifestations that can develop in the context of ANCA-associated vasculitis, detailing the clinical features, the histopathological aspects as well as the direct immunofluorescence studies for each of the three conditions. Moreover, we acknowledged the differential diagnoses that must be ruled out in the diagnostic process and the main therapeutic approaches available for treatment of ANCA-associated vasculitis.
Literatur
3.
Zurück zum Zitat Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X (2016) Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum dis 76(4):647–653. doi:10.1136/annrheumdis-2016-209507 CrossRefPubMed Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X (2016) Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum dis 76(4):647–653. doi:10.​1136/​annrheumdis-2016-209507 CrossRefPubMed
5.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. doi:10.1002/art.37715 CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. doi:10.​1002/​art.​37715 CrossRefPubMed
6.
Zurück zum Zitat Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14–i22. doi:10.1093/ndt/gfv022 CrossRefPubMed Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suarez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):i14–i22. doi:10.​1093/​ndt/​gfv022 CrossRefPubMed
7.
Zurück zum Zitat Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12):1560–1565. doi:10.1093/rheumatology/kep304 CrossRef Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12):1560–1565. doi:10.​1093/​rheumatology/​kep304 CrossRef
9.
Zurück zum Zitat Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A (2017) ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr 43(1):46. doi:10.1186/s13052-017-0364-x CrossRefPubMedPubMedCentral Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A (2017) ANCA-associated vasculitis in childhood: recent advances. Ital J Pediatr 43(1):46. doi:10.​1186/​s13052-017-0364-x CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern med 116(6):488–498CrossRefPubMed Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern med 116(6):488–498CrossRefPubMed
12.
Zurück zum Zitat Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–2349. doi:10.1093/ndt/gfr643 CrossRefPubMed Chang DY, Wu LH, Liu G, Chen M, Kallenberg CG, Zhao MH (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27(6):2343–2349. doi:10.​1093/​ndt/​gfr643 CrossRefPubMed
13.
Zurück zum Zitat Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study G (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum dis 67(7):1004–1010. doi:10.1136/ard.2007.071936 CrossRefPubMed Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, European Vasculitis Study G (2008) Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European league against rheumatism systemic vasculitis task force. Ann Rheum dis 67(7):1004–1010. doi:10.​1136/​ard.​2007.​071936 CrossRefPubMed
14.
Zurück zum Zitat Stone JH, Wegener’s Granulomatosis Etanercept Trial Research G (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309. doi:10.1002/art.11075 CrossRefPubMed Stone JH, Wegener’s Granulomatosis Etanercept Trial Research G (2003) Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum 48(8):2299–2309. doi:10.​1002/​art.​11075 CrossRefPubMed
15.
Zurück zum Zitat Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N (2011) Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatology (Oxford) 50(4):697–702. doi:10.1093/rheumatology/keq351 CrossRef Luqmani R, Suppiah R, Edwards CJ, Phillip R, Maskell J, Culliford D, Jayne D, Morishita K, Arden N (2011) Mortality in Wegener’s granulomatosis: a bimodal pattern. Rheumatology (Oxford) 50(4):697–702. doi:10.​1093/​rheumatology/​keq351 CrossRef
17.
Zurück zum Zitat Patten SF, Tomecki KJ (1993) Wegener’s granulomatosis: cutaneous and oral mucosal disease. J am Acad Dermatol 28(5 Pt 1):710–718CrossRefPubMed Patten SF, Tomecki KJ (1993) Wegener’s granulomatosis: cutaneous and oral mucosal disease. J am Acad Dermatol 28(5 Pt 1):710–718CrossRefPubMed
20.
Zurück zum Zitat Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, Csernok E, Moosig F, Schinke S, Reinhold-Keller E (2010) Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69(11):1934–1939. doi:10.1136/ard.2010.130203 CrossRefPubMed Holle JU, Gross WL, Holl-Ulrich K, Ambrosch P, Noelle B, Both M, Csernok E, Moosig F, Schinke S, Reinhold-Keller E (2010) Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis 69(11):1934–1939. doi:10.​1136/​ard.​2010.​130203 CrossRefPubMed
23.
Zurück zum Zitat Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Calamia K, Migliorati C, Baughman R, Langford P, Katz J (2007) Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138(3):338–348 quiz 396, 398CrossRefPubMed Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Calamia K, Migliorati C, Baughman R, Langford P, Katz J (2007) Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 138(3):338–348 quiz 396, 398CrossRefPubMed
24.
Zurück zum Zitat Marzano AV, Balice Y, Tavecchio S, Desimine C, Colombo A, Berti E (2015) Granulomatous vasculitis. G Ital Dermatol Venereol 150(2):193–202PubMed Marzano AV, Balice Y, Tavecchio S, Desimine C, Colombo A, Berti E (2015) Granulomatous vasculitis. G Ital Dermatol Venereol 150(2):193–202PubMed
25.
Zurück zum Zitat Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials O (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum dis 69(5):798–806. doi:10.1136/ard.2009.116657 CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials O (2010) EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum dis 69(5):798–806. doi:10.​1136/​ard.​2009.​116657 CrossRefPubMed
26.
Zurück zum Zitat Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B (2013) Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol 30(4):e37–e42. doi:10.1111/pde.12034 CrossRefPubMed Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B (2013) Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol 30(4):e37–e42. doi:10.​1111/​pde.​12034 CrossRefPubMed
27.
Zurück zum Zitat Decleva I, Marzano AV, Barbareschi M, Berti E (1997) Cutaneous manifestations in systemic vasculitis. Clin rev Allergy Immunol 15(1):5–20CrossRefPubMed Decleva I, Marzano AV, Barbareschi M, Berti E (1997) Cutaneous manifestations in systemic vasculitis. Clin rev Allergy Immunol 15(1):5–20CrossRefPubMed
30.
Zurück zum Zitat Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C (2006) Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47(5):770–779. doi:10.1053/j.ajkd.2006.01.026 CrossRefPubMed Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C (2006) Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47(5):770–779. doi:10.​1053/​j.​ajkd.​2006.​01.​026 CrossRefPubMed
31.
Zurück zum Zitat Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study G (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270–281. doi:10.1002/art.37721 CrossRefPubMed Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L, French Vasculitis Study G (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term follow-up of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270–281. doi:10.​1002/​art.​37721 CrossRefPubMed
32.
Zurück zum Zitat Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, Lauque D, Viallard JF, Zoulim A, Guillevin L, French Vasculitis Study G (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143(9):632–638CrossRefPubMed Sable-Fourtassou R, Cohen P, Mahr A, Pagnoux C, Mouthon L, Jayne D, Blockmans D, Cordier JF, Delaval P, Puechal X, Lauque D, Viallard JF, Zoulim A, Guillevin L, French Vasculitis Study G (2005) Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143(9):632–638CrossRefPubMed
34.
35.
Zurück zum Zitat Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46(8):1329–1337. doi:10.1093/rheumatology/kem107 CrossRef Mohammad AJ, Jacobsson LT, Mahr AD, Sturfelt G, Segelmark M (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46(8):1329–1337. doi:10.​1093/​rheumatology/​kem107 CrossRef
37.
Zurück zum Zitat Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156(4):440–445CrossRefPubMed Niles JL, Bottinger EP, Saurina GR, Kelly KJ, Pan G, Collins AB, McCluskey RT (1996) The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156(4):440–445CrossRefPubMed
38.
Zurück zum Zitat Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56(220):467–483PubMed Savage CO, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 56(220):467–483PubMed
41.
Zurück zum Zitat Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, Ozaki S, Mizoguchi M (2006) Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 86(2):144–147. doi:10.2340/00015555-0034 PubMed Kawakami T, Soma Y, Saito C, Ogawa H, Nagahuchi Y, Okazaki T, Ozaki S, Mizoguchi M (2006) Cutaneous manifestations in patients with microscopic polyangiitis: two case reports and a minireview. Acta Derm Venereol 86(2):144–147. doi:10.​2340/​00015555-0034 PubMed
44.
Zurück zum Zitat Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148(2):185–196PubMed Marzano AV, Menicanti C, Crosti C, Trevisan V (2013) Neutrophilic dermatoses and inflammatory bowel diseases. G Ital Dermatol Venereol 148(2):185–196PubMed
45.
Zurück zum Zitat Seishima M, Oyama Z, Oda M (2004) Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 14(4):255–258PubMed Seishima M, Oyama Z, Oda M (2004) Skin eruptions associated with microscopic polyangiitis. Eur J Dermatol 14(4):255–258PubMed
51.
Zurück zum Zitat Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210. doi:10.1007/s12016-012-8351-x CrossRefPubMed Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210. doi:10.​1007/​s12016-012-8351-x CrossRefPubMed
53.
Zurück zum Zitat Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 178(1):48–56. doi:10.1111/cei.12394 CrossRefPubMedPubMedCentral Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol 178(1):48–56. doi:10.​1111/​cei.​12394 CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Gastman B, Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Fernandez A, Zins J, Hoffman GS, Doumit G, Siemionow M, Papay F (2016) Malignant pyoderma associated with granulomatosis with polyangiitis (Wegener granulomatosis) as a unique indication for facial vascularized composite Allotransplantation: part I. Plast Reconstr Surg 137(6):1007e–1015e. doi:10.1097/PRS.0000000000002162 CrossRefPubMed Gastman B, Hashem AM, Djohan R, Bernard S, Hendrickson M, Schwarz G, Gharb BB, Rampazzo A, Fernandez A, Zins J, Hoffman GS, Doumit G, Siemionow M, Papay F (2016) Malignant pyoderma associated with granulomatosis with polyangiitis (Wegener granulomatosis) as a unique indication for facial vascularized composite Allotransplantation: part I. Plast Reconstr Surg 137(6):1007e–1015e. doi:10.​1097/​PRS.​0000000000002162​ CrossRefPubMed
55.
Zurück zum Zitat Jeong HS, Layher H, Cao L, Vandergriff T, Dominguez AR (2016) Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: clinical, serologic, and histopathologic findings in a cohort of patients. J am Acad Dermatol 74(5):892–898. doi:10.1016/j.jaad.2015.11.040 CrossRefPubMed Jeong HS, Layher H, Cao L, Vandergriff T, Dominguez AR (2016) Pyoderma gangrenosum (PG) associated with levamisole-adulterated cocaine: clinical, serologic, and histopathologic findings in a cohort of patients. J am Acad Dermatol 74(5):892–898. doi:10.​1016/​j.​jaad.​2015.​11.​040 CrossRefPubMed
56.
Zurück zum Zitat Jimenez-Gallo D, Albarran-Planelles C, Linares-Barrios M, Rodriguez-Hernandez C, Martinez-Rodriguez A, Garcia-Moreno E, Bravo-Monge R (2013) Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin Exp Dermatol 38(8):878–882. doi:10.1111/ced.12207 CrossRefPubMed Jimenez-Gallo D, Albarran-Planelles C, Linares-Barrios M, Rodriguez-Hernandez C, Martinez-Rodriguez A, Garcia-Moreno E, Bravo-Monge R (2013) Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin Exp Dermatol 38(8):878–882. doi:10.​1111/​ced.​12207 CrossRefPubMed
58.
Zurück zum Zitat Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum dis 75(9):1583–1594. doi:10.1136/annrheumdis-2016-209133 CrossRefPubMed Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, Hellmich B, Holle JU, Laudien M, Little MA, Luqmani RA, Mahr A, Merkel PA, Mills J, Mooney J, Segelmark M, Tesar V, Westman K, Vaglio A, Yalcindag N, Jayne DR, Mukhtyar C (2016) EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum dis 75(9):1583–1594. doi:10.​1136/​annrheumdis-2016-209133 CrossRefPubMed
59.
Zurück zum Zitat Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M (1997) A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum 40(12):2187–2198. doi:10.1002/1529-0131 (199712)40:12<2187::AID-ART12>3.0.CO;2-HCrossRefPubMed Guillevin L, Cordier JF, Lhote F, Cohen P, Jarrousse B, Royer I, Lesavre P, Jacquot C, Bindi P, Bielefeld P, Desson JF, Detree F, Dubois A, Hachulla E, Hoen B, Jacomy D, Seigneuric C, Lauque D, Stern M, Longy-Boursier M (1997) A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener’s granulomatosis. Arthritis Rheum 40(12):2187–2198. doi:10.​1002/​1529-0131 (199712)40:12<2187::AID-ART12>3.0.CO;2-HCrossRefPubMed
60.
Zurück zum Zitat Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study G (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36–44. doi:10.1056/NEJMoa020286 CrossRefPubMed Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C, European Vasculitis Study G (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349(1):36–44. doi:10.​1056/​NEJMoa020286 CrossRefPubMed
61.
Zurück zum Zitat Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143(9):621–631CrossRefPubMed
62.
Zurück zum Zitat De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(8):2461–2469. doi:10.1002/art.21142 CrossRefPubMed De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52(8):2461–2469. doi:10.​1002/​art.​21142 CrossRefPubMed
63.
Zurück zum Zitat Wegener’s Granulomatosis Etanercept Trial Research G (2005) Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 352(4):351–361. doi:10.1056/NEJMoa041884 CrossRef Wegener’s Granulomatosis Etanercept Trial Research G (2005) Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 352(4):351–361. doi:10.​1056/​NEJMoa041884 CrossRef
64.
Zurück zum Zitat Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puechal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study G (2008) Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J med 359(26):2790–2803. doi:10.1056/NEJMoa0802311 CrossRefPubMed Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puechal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L, French Vasculitis Study G (2008) Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J med 359(26):2790–2803. doi:10.​1056/​NEJMoa0802311 CrossRefPubMed
65.
Zurück zum Zitat de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, Euvas (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150(10):670–680CrossRefPubMed de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, Tesar V, Vanhille P, Westman K, Savage CO, Euvas (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150(10):670–680CrossRefPubMed
67.
Zurück zum Zitat Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, Group R-IR (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232. doi:10.1056/NEJMoa0909905 CrossRefPubMedPubMedCentral Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, Group R-IR (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363(3):221–232. doi:10.​1056/​NEJMoa0909905 CrossRefPubMedPubMedCentral
68.
Zurück zum Zitat Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, Group R-IR (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369(5):417–427. doi:10.1056/NEJMoa1213277 CrossRefPubMed Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, Group R-IR (2013) Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med 369(5):417–427. doi:10.​1056/​NEJMoa1213277 CrossRefPubMed
Metadaten
Titel
Cutaneous Manifestations of ANCA-Associated Small Vessels Vasculitis
verfasst von
Angelo Valerio Marzano
Maria Gabriella Raimondo
Emilio Berti
Pier Luigi Meroni
Francesca Ingegnoli
Publikationsdatum
03.06.2017
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2017
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-017-8616-5

Weitere Artikel der Ausgabe 3/2017

Clinical Reviews in Allergy & Immunology 3/2017 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

HNO-Op. auch mit über 90?

16.04.2024 HNO-Chirurgie Nachrichten

Mit Blick auf das Risiko für Komplikationen nach elektiven Eingriffen im HNO-Bereich scheint das Alter der Patienten kein ausschlaggebender Faktor zu sein. Entscheidend ist offenbar, wie fit die Betroffenen tatsächlich sind.

Intrakapsuläre Tonsillektomie gewinnt an Boden

16.04.2024 Tonsillektomie Nachrichten

Gegenüber der vollständigen Entfernung der Gaumenmandeln hat die intrakapsuläre Tonsillektomie einige Vorteile, wie HNO-Fachleute aus den USA hervorheben. Sie haben die aktuelle Literatur zu dem Verfahren gesichtet.

Bilateraler Hörsturz hat eine schlechte Prognose

15.04.2024 Hörsturz Nachrichten

Die Mehrzahl der Menschen mit Hörsturz ist einseitig betroffen, doch auch ein beidseitiger Hörsturz ist möglich. Wie häufig solche Fälle sind und wie sich ihr Verlauf darstellt, hat eine HNO-Expertenrunde aus den USA untersucht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.